Table 3.
Co-occurring psychiatric and medical concerns (N = 42)
Comorbid diagnosis | % | n |
---|---|---|
Psychiatric | 90.5 | 38 |
Neurodevelopmental disorders | 42.9 | 18 |
Autism spectrum disorder | 16.7 | 7 |
Attention deficit hyperactivity disorder | 26.2 | 11 |
Learning disability or intellectual disability | 14.3 | 6 |
Mood disorders | 52.4 | 22 |
Major depressive disorder (or other similar depressive disorder) | 47.6 | 20 |
Bipolar disorder | 4.8 | 2 |
Anxiety disorders | 61.9 | 26 |
Generalized anxiety disorder | 50.0 | 21 |
Social anxiety disorder | 16.7 | 7 |
Other Anxiety Disordera | 16.7 | 7 |
Unspecified anxiety disorder | 4.8 | 2 |
Obsessive compulsive disorder | 16.7 | 7 |
Posttraumatic stress disorder or other trauma/stressor-related disorder | 21.4 | 9 |
Substance use disorder | 4.8 | 2 |
Borderline personality disorder | 9.5 | 4 |
Somatic symptom disorder | 7.1 | 3 |
Medical | 35.7 | 15 |
Celiac disease | 7.1 | 3 |
Crohn’s disease | 7.1 | 3 |
GERD | 7.1 | 3 |
Food allergies | 7.1 | 3 |
Other gastrointestinal disorders | 3.1 | 3 |
Other conditions affecting food or eating | 9.5 | 4 |
Comorbid concerns were obtained from chart review based on either what was diagnosed following assessment in our program, or noted at assessment as a pre-existing diagnosis within the clinical record or self-reported by the patient. We combined some categories with small ns to ensure de-identification
a“Other anxiety disorder” included individuals diagnosed with any of the following: specific phobia, panic disorder, agoraphobia, or selective mutism